Today

Agents

Chat

Arena

Discover

More

App

Bio-Techne Q4 Adjusted EPS USD 0.52 Vs. IBES Estimate USD 0.52 - TECH News | Rallies

Bio-Techne Q4 Adjusted EPS USD 0.52 Vs. IBES Estimate USD 0.52

TECH•2026-08-12

Bio-Techne reports fourth-quarter results

Aug. 12 (Reuters) - Bio-Techne Q4 operating income was USD 74.277 million.

Q4 pretax profit: USD 70.681 million
Q4 operating expenses: USD 137.117 million
Q4 revenue: USD 321.191 million vs. IBES estimate of USD 314.7 million
Q4 net income: USD 54.622 million
Q4 EPS: USD 0.35

Related News

CoreWeave, Inc. <CRWV.O>: Barclays Raises Target Price to $105 From $90

CRWV•2026-08-12

Xilio net loss narrows to $6.4 million in Q2 FY26; revenue more than doubles to $18.7 million

XLO•2026-08-12

Kamada Announces Planned Transition Of Chief Financial Officer

•

2026-08-12

Unicycive Therapeutics Announces Second Quarter 2026 Financial Results And Provides Business Update

UNCY•2026-08-12

Agilent Technologies, Inc. <A.N>: Morgan Stanley Raises Target Price to $175.00 From $160.00